We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.13%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.68B
AUM Growth
-$63.5M
Cap. Flow
-$190M
Cap. Flow %
-5.16%
Top 10 Hldgs %
14.27%
Holding
1,438
New
94
Increased
433
Reduced
653
Closed
139

Sector Composition

Rank Sector Weight
1 Technology 13.28%
2 Healthcare 12.17%
3 Financials 11.04%
4 Consumer Discretionary 8.91%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNDT
376
DELISTED
Mandiant, Inc. Common Stock
MNDT
$2.17M 0.06%
146,270
-45,269
-24% -$694K
CTSH icon
377
Cognizant
CTSH
$24.9B
$2.16M 0.06%
34,058
-16,995
-33% -$1.12M
EQR icon
378
Equity Residential
EQR
$24.9B
$2.14M 0.06%
28,247
+15
+0.1% +$1.15K
SMH icon
379
VanEck Semiconductor ETF
SMH
$65.2B
$2.14M 0.06%
+38,782
New +$2.11M
MAS icon
380
Masco
MAS
$14.1B
$2.13M 0.06%
54,309
-6,288
-10% -$242K
TROW icon
381
T. Rowe Price
TROW
$23.9B
$2.13M 0.06%
19,410
-422
-2% -$44.4K
ETG
382
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.8B
$2.13M 0.06%
132,396
-6,780
-5% -$107K
LVS icon
383
Las Vegas Sands
LVS
$31.7B
$2.13M 0.06%
35,964
-7,158
-17% -$443K
IP icon
384
International Paper
IP
$21.6B
$2.12M 0.06%
51,776
-2,205
-4% -$93.4K
ALXN
385
DELISTED
Alexion Pharmaceuticals
ALXN
$2.1M 0.06%
16,071
-287
-2% -$37K
DIA icon
386
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
$2.1M 0.06%
7,881
-3,199
-29% -$835K
SPYD icon
387
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.62B
$2.08M 0.06%
+54,708
New +$2.07M
VCR icon
388
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$2.08M 0.06%
11,598
+761
+7% +$134K
ISRG icon
389
Intuitive Surgical
ISRG
$127B
$2.08M 0.06%
11,895
-16,443
-58% -$2.82M
QTEC icon
390
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.52B
$2.08M 0.06%
24,294
-3,874
-14% -$326K
MITT
391
TPG Mortgage Investment Trust
MITT
$222M
$2.03M 0.06%
42,644
-3,280
-7% -$162K
SYY icon
392
Sysco
SYY
$40.8B
$2.02M 0.05%
28,544
-3,839
-12% -$273K
FXL icon
393
First Trust Technology AlphaDEX Fund
FXL
$2.53B
$2.02M 0.05%
30,321
-4,297
-12% -$281K
PANW icon
394
Palo Alto Networks
PANW
$270B
$2.02M 0.05%
59,370
-15,378
-21% -$575K
SCHW
395
Charles Schwab
SCHW
$183B
$2.01M 0.05%
49,980
+6,142
+14% +$268K
MU icon
396
Micron Technology
MU
$930B
$2M 0.05%
51,685
-25,850
-33% -$985K
FIW icon
397
First Trust Water ETF
FIW
$1.85B
$1.97M 0.05%
36,082
-4,362
-11% -$227K
AMLP icon
398
Alerian MLP ETF
AMLP
$13B
$1.95M 0.05%
39,676
-28,320
-42% -$1.4M
FND icon
399
Floor & Decor
FND
$6.22B
$1.95M 0.05%
46,580
+6,980
+18% +$292K
IWD icon
400
iShares Russell 1000 Value ETF
IWD
$82.2B
$1.95M 0.05%
15,319
-3,079
-17% -$385K

Similar funds

Oppenheimer & Co's Q2 2019 Portfolio in Review

As of Q2 2019, Oppenheimer & Co held 1,438 positions worth $3.68B, down 1.7% from $3.74B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $190M in Q2 2019, closing 139 positions and reducing 653 holdings. Its most notable exit was Amber Road Inc, an estimated $2.06M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in Dow Inc worth $8.02M.

  • Oppenheimer & Co's largest Q2 2019 buy was Dow Inc: 162,710 shares worth $8.02M.
  • Oppenheimer & Co added most to Occidental Petroleum in Q2 2019, an estimated $4.3M increase.
  • Oppenheimer & Co's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $17.5M.
  • Oppenheimer & Co fully exited Amber Road Inc in Q2 2019, selling an estimated $2.06M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2019.
  • Oppenheimer & Co opened 94 new positions and closed 139 in Q2 2019.
  • Oppenheimer & Co's portfolio value fell 1.7% quarter-over-quarter to $3.68B.

Based on Oppenheimer & Co's 13F filing for Q2 2019, filed 9 Aug 2019.